The Latest Breaking News from Vaccine

A city health chief says there are insufficient supplies for Newcastle to catch up with other areas that have higher rates of protection from the virus

People in the underweight and obese groups are still at significantly higher risk, though

Here's a roundup of top developments in the biotech space over the last 24 hours:

The FDA's independent experts voted to include a SARS-CoV-2 omicron component in COVID-19 vaccines that would be used for boosters in the U.S. beginning in fall 2022. The panel has advised manufacturers to develop modified vaccines that add an omicron BA.4/5 spike protein component to the current vaccine composition to create a…

Since the pandemic began, more than 6 million people have died from COVID around the world. The good news is that we now have a wide range of treatments as well as highly effective vaccines which have helped reduce the number of severe COVID cases.

‘Living with the virus’ is proving much harder than the early vaccine success suggested, says professor of immunology Danny Altmann

Covid-19 cases have surged again to 300,000 new infections per day - the latest variant in circulation is thought to have caused an increase in reinfections despite vaccine take-up and natural immunity

Oxford Biomedica plc (OTC:OXBDF) signed a new three-year agreement to potentially make AstraZeneca Plc's (NASDAQ:AZN) COVID-19 vaccine beyond 2022. The new agreement represents an expansion of the original master supply and development agreement announced between the two companies in September 2020. The manufacture of COVID-19 vaccines at Oxford Biomedica's Oxbox facility, as part of the…

"Covid-19 is still out there"

United States Supreme Court Associate Justice Clarence Thomas has received heated response to the claim

TAMPA, Fla. -- It’s been almost two weeks since federal regulators authorized COVID-19 vaccines for infants and preschoolers, but Katie Old Crow still hasn’t been able to get her 14-month-old son vaccinated.